LD
Lingarao Donthineni
About Lingarao Donthineni
Data last updated:
Lingarao Donthineni is a Whole-Time Director at Natco Pharma Limited (since 2015). The company operates in Agriculture. Natco Pharma Limited reported revenue of ₹4,784 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 11 Feb 2015 | 1981 | ₹4,784 Cr (FY 2025) | Active |
Board colleagues of Lingarao Donthineni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Agnihotra Dakshina Murty Chavali | 00374673 | Natco Pharma Limited | Director |
| Amit Parekh | Natco Pharma Limited | Cfo | |
| Lakshminarayana Bolisetty | 02766709 | Natco Pharma Limited | Director |
| Nitin Jain | 00136245 | Natco Pharma Limited | Director |
| Potluri Prasad Sivaramakrishna | 07011140 | Natco Pharma Limited | Whole-Time Director |
| Rajeev Nannapaneni | 00183872 | Natco Pharma Limited | Whole-Time Director |
| Suma Kantipudi | 02734369 | Natco Pharma Limited | Director |
| Venkaiah Chowdary Nannapaneni | 00183315 | Natco Pharma Limited | Managing Director |
| Venkat Ramesh Chekuri | Natco Pharma Limited | Company Secretary | |
| Vijayabhaskar Dronadula | 07158951 | Natco Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lingarao Donthineni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lingarao Donthineni
Lingarao Donthineni currently holds 1 directorship: Natco Pharma Limited (Whole-Time Director, since 11 Feb 2015, revenue ₹4,784 Cr (FY 2025)).
Lingarao Donthineni was first appointed on 11 Feb 2015 as Whole-Time Director at Natco Pharma Limited.
The current boards of Lingarao Donthineni's companies include Agnihotra Dakshina Murty Chavali (Natco Pharma Limited), Amit Parekh (Natco Pharma Limited), Lakshminarayana Bolisetty (Natco Pharma Limited), Nitin Jain (Natco Pharma Limited), Potluri Prasad Sivaramakrishna (Natco Pharma Limited), Rajeev Nannapaneni (Natco Pharma Limited), among others.